RxDoctor Payments Data

Kara Davis

Pediatric Hematology-Oncology · Palo Alto, CANPI 1174647507

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 2025 is the largest year on record at $3,473, more than ten times the $61 reported in 2019.

$6,599in general payments, 2019–2025

Across 5 payments — averaging $1319.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$3K
  • Novartis$3K
$1,248,730in research payments, 2019–2025

Across 43 payments — averaging $29,040 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$906K
  • Jazz Pharmaceuticals Inc.$305K
  • BD$21K
  • AbbVie$17K

What the payments were for

  • Consulting fees$3,06546%
  • Speaking & faculty fees$3,34851%
  • Food & beverage$1863%

General payments by program year

19
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Jazz Pharmaceuticals Inc.2$3,473
Novartis3$3,126

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,599 in reported general payments places this provider in the 70th percentile of 307 pediatric hematology-oncology providers in California.

See all pediatric hematology-oncology providers in California

Other pediatric hematology-oncology in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →